Dabur India Q1 FY27 Share Price & Earnings Call Analysis
- Market cap
- ₹64,856 Cr
- P/E
- 32.70
- ROE
- 17.00%
- PEG
- 8.89
- Price to sales
- 4.78
- Debt to equity
- 0.11
- 52W high / low
- ₹525 / ₹358
- Sales growth (5Y)
- 6.65%
- EBITDA margin
- 18.62%
- Net profit margin
- 14.11%
- Promoter holding
- 66.25%
- Sales (last year)
- ₹13,552 Cr
Dabur is India’s leading FMCG, Ayurvedic and natural health care company with wide network distribution across world. [1]
Guidance scorecard · Q1 FY27 call
What Dabur India Ltd's management guided
and where it ranks in Personal Products
Personal Products
RevenueQ1 FY27 call
10–20%- Dabur India Limited projects double-digit consolidated revenue growth for FY27, driven by both India and international businesses.
- India FMCG business expects around 9.5% revenue growth with approximately 5% volume growth.
- Hair oil business targets double-digit value growth, supported by 8% volume growth.
- Volume growth overall is expected to be under pressure due to inflation; revenue growth will be more driven by price increases.
- The company remains confident about maintaining 14%-15% PAT (profit after tax) growth at consolidated level if double-digit top-line growth continues.
- Rural demand remains resilient and growing ahead of urban, supporting future sales.
- Innovation and premiumization strategies, including new launches like Vatika’s Bio-Infusions and D2C initiatives, support growth.
2 more points from Dabur India Ltd's call on revenue
Create a free account to keep reading this call
MarginsQ1 FY27 call
FlatSee what Dabur India Ltd said on margins — free account, 30 seconds.
CapexQ1 FY27 call
Planned- Dabur India Limited has allocated approximately INR 400-500 crores for greenfield capex projects, including investments in Tamil Nadu, which will consume cash.
- There is an earmarked INR 500 crores for strategic acquisitions, especially targeting mid to large scale companies or to gain a foothold in Direct-to-Consumer (D2C) businesses through Dabur Ventures.
- The company aims to acquire 1 or 2 sizable companies within the next 3 years as part of its strategic acquisition plan.
- Routine capex for expansion is ongoing to support business growth.
2 more points from Dabur India Ltd's call on capex
Create a free account to keep reading this call
FundraisingQ1 FY27 call
None plannedSee what Dabur India Ltd said on fundraising — free account, 30 seconds.
Order bookQ1 FY27 call
Ask what Dabur India Ltd said on the order book →
Full Q1 FY27 analysisRanges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.
Potential multibaggers · Q2 FY27
Potential multibaggers in Personal Products
on management's own guidance
- Strong growth2
- Strong growth1
- Honasa Consumer LtdGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Personal Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹2,041 Cr | 61.0 | |
| 2 | 40%+ | Flat | ₹400 Cr | 35.6 | |
| 3 | Honasa Consumer Ltd | 20–40% | Up 0–2% | ₹14,745 Cr | 58.4 |
| 4 | 10–20% | Flat | ₹87,493 Cr | 42.1 | |
| 5 | Dabur India LtdThis stock | 10–20% | Flat | ₹68,298 Cr | 34.4 |
| 6 | 10–20% | Flat | ₹16,419 Cr | 21.7 |
Sign up free to see every company in the sector ranking and track Dabur India Ltd.
Pro shows every company guiding 40%+ revenue growth →Full Personal Products rankingDabur India Ltd announcements
All announcements →- Acquisition / mergerNotableDabur India: NCLT sanctions amalgamation of Sesa Care Private Limited with the company
Financials of Dabur India Ltd
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Dabur India Ltd
Quarterly Results
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 2,678 | 3,130 | 3,204 | 3,255 | 2,815 | 3,349 | 3,029 | 3,355 | 2,830 | 3,405 | 3,191 | 3,559 | 3,038 |
| Expenses + | 2,268 | 2,526 | 2,543 | 2,588 | 2,348 | 2,694 | 2,476 | 2,673 | 2,403 | 2,737 | 2,603 | 2,825 | 2,577 |
| Operating Profit | 410 | 605 | 661 | 667 | 466 | 655 | 553 | 682 | 427 | 667 | 588 | 734 | 461 |
| OPM % | 15% | 19% | 21% | 20% | 17% | 20% | 18% | 20% | 15% | 20% | 18% | 21% | 15% |
| Other Income + | 121 | 110 | 117 | 127 | 129 | 129 | 152 | 129 | 141 | 144 | 140 | 126 | 175 |
| Interest | 32 | 24 | 28 | 36 | 35 | 33 | 47 | 44 | 39 | 35 | 40 | 31 | 40 |
| Depreciation | 102 | 97 | 98 | 97 | 107 | 109 | 111 | 109 | 117 | 114 | 115 | 117 | 122 |
| Profit before tax | 396 | 593 | 651 | 661 | 453 | 642 | 546 | 658 | 412 | 663 | 573 | 711 | 474 |
| Tax % | 26% | 23% | 22% | 23% | 25% | 23% | 24% | 22% | 24% | 23% | 22% | 22% | 24% |
| Net Profit + | 293 | 457 | 507 | 506 | 341 | 494 | 418 | 516 | 313 | 508 | 445 | 554 | 362 |
| EPS in Rs | 1.70 | 2.62 | 2.91 | 2.90 | 1.97 | 2.82 | 2.40 | 2.95 | 1.81 | 2.90 | 2.55 | 3.16 | 2.08 |
Financials of Dabur India Ltd
Profit & Loss
Annual income statement trend
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 7,795 | 7,780 | 7,614 | 7,722 | 8,515 | 8,685 | 9,562 | 10,889 | 11,530 | 12,404 | 12,563 | 13,193 |
| Expenses + | 6,475 | 6,261 | 6,102 | 6,104 | 6,775 | 6,892 | 7,560 | 8,637 | 9,367 | 10,004 | 10,247 | 10,743 |
| Operating Profit | 1,320 | 1,518 | 1,512 | 1,617 | 1,740 | 1,792 | 2,002 | 2,252 | 2,162 | 2,400 | 2,316 | 2,450 |
| OPM % | 17% | 20% | 20% | 21% | 20% | 21% | 21% | 21% | 19% | 19% | 18% | 19% |
| Other Income + | 154 | 217 | 296 | 291 | 222 | 205 | 325 | 308 | 445 | 482 | 551 | 585 |
| Interest | 40 | 48 | 54 | 53 | 60 | 50 | 31 | 39 | 78 | 124 | 164 | 145 |
| Depreciation | 115 | 133 | 143 | 162 | 177 | 220 | 240 | 253 | 311 | 399 | 446 | 469 |
| Profit before tax | 1,319 | 1,554 | 1,611 | 1,693 | 1,725 | 1,728 | 2,056 | 2,269 | 2,219 | 2,359 | 2,258 | 2,420 |
| Tax % | 19% | 19% | 21% | 20% | 16% | 16% | 18% | 23% | 23% | 23% | 23% | 23% |
| Net Profit + | 1,068 | 1,254 | 1,280 | 1,358 | 1,446 | 1,448 | 1,695 | 1,742 | 1,701 | 1,811 | 1,740 | 1,869 |
| EPS in Rs | 6.07 | 7.11 | 7.25 | 7.69 | 8.17 | 8.18 | 9.58 | 9.84 | 9.64 | 10.40 | 9.97 | 10.68 |
| Dividend Payout % | 33% | 32% | 31% | 81% | 34% | 37% | 50% | 53% | 54% | 53% | 80% | 77% |
Financials of Dabur India Ltd
Balance Sheet
Capital structure and asset base
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 176 | 176 | 176 | 176 | 177 | 177 | 177 | 177 | 177 | 177 | 177 | 177 |
| Reserves | 3,178 | 3,995 | 4,671 | 5,530 | 5,455 | 6,429 | 7,487 | 8,205 | 8,796 | 9,689 | 10,623 | 11,242 |
| Borrowings + | 734 | 805 | 975 | 938 | 699 | 522 | 509 | 1,030 | 1,174 | 1,365 | 950 | 1,287 |
| Other Liabilities + | 2,019 | 1,956 | 1,910 | 2,058 | 2,106 | 2,209 | 2,661 | 2,872 | 3,505 | 3,885 | 4,479 | 4,773 |
| Total Liabilities | 6,106 | 6,932 | 7,732 | 8,702 | 8,437 | 9,337 | 10,833 | 12,284 | 13,652 | 15,116 | 16,230 | 17,480 |
| Fixed Assets + | 1,877 | 1,667 | 1,958 | 2,028 | 1,969 | 2,253 | 2,243 | 2,308 | 3,579 | 3,815 | 3,990 | 3,939 |
| CWIP | 50 | 45 | 42 | 42 | 64 | 147 | 147 | 168 | 175 | 232 | 169 | 137 |
| Investments | 1,813 | 2,691 | 3,240 | 3,805 | 3,359 | 2,800 | 4,160 | 6,220 | 6,265 | 6,933 | 7,468 | 8,947 |
| Other Assets + | 2,365 | 2,529 | 2,492 | 2,827 | 3,045 | 4,137 | 4,283 | 3,589 | 3,633 | 4,136 | 4,603 | 4,456 |
| Total Assets | 6,106 | 6,932 | 7,732 | 8,702 | 8,437 | 9,337 | 10,833 | 12,284 | 13,652 | 15,116 | 16,230 | 17,480 |
Financials of Dabur India Ltd
Cash Flows
Operating, investing and financing cash movement
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 1,047 | 1,187 | 1,227 | 1,092 | 1,499 | 1,614 | 2,115 | 1,802 | 1,488 | 2,013 | 1,987 | 2,579 |
| Cash from Investing Activity + | -876 | -730 | -807 | -541 | 338 | -517 | -1,404 | -1,273 | -583 | -971 | -448 | -1,285 |
| Cash from Financing Activity + | -417 | -374 | -339 | -577 | -1,888 | -1,043 | -613 | -490 | -1,035 | -1,161 | -1,405 | -1,236 |
| Net Cash Flow | -245 | 82 | 81 | -27 | -51 | 54 | 97 | 38 | -130 | -119 | 133 | 58 |
| Free Cash Flow | 796 | 998 | 741 | 891 | 1,274 | 1,213 | 1,808 | 1,433 | 1,003 | 1,453 | 1,448 | 2,180 |
| CFO/OP | 97% | 97% | 102% | 88% | 106% | 107% | 122% | 97% | 92% | 104% | 103% | 122% |
Financials of Dabur India Ltd
Ratios
Working capital efficiency and return ratios
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 33 | 38 | 31 | 33 | 36 | 34 | 21 | 22 | 27 | 26 | 26 | 20 |
| Inventory Days | 136 | 150 | 153 | 169 | 154 | 164 | 178 | 169 | 158 | 149 | 175 | 124 |
| Days Payable | 153 | 182 | 181 | 190 | 172 | 176 | 197 | 178 | 171 | 186 | 215 | 158 |
| Cash Conversion Cycle | 16 | 6 | 3 | 13 | 17 | 22 | 3 | 12 | 14 | -10 | -14 | -14 |
| Working Capital Days | -17 | -0 | -7 | -1 | -5 | 9 | -9 | -14 | -13 | -17 | -13 | 85 |
| ROCE % | 36% | 35% | 31% | 28% | 28% | 28% | 27% | 27% | 23% | 22% | 20% | 20% |
Guidance history
How Dabur India Ltd's guidance has moved, call by call
| Call | Revenue | Margins | Capex | Fundraising | Order book |
|---|---|---|---|---|---|
| Q1 FY27 call → | 10–20% | Flat | Planned | None planned | — |
| Q3 FY26 call → | 10–20% | Up 0–2% | — | — | — |
| Q2 FY26 call → | 0–10% | Flat | Planned | None planned | — |
What management guided on each call, newest first. Not investment advice, and not a forecast of returns.
Momentum score · price trend
15 out of 100 — Cooling
Over the past year its share price has done worse than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | −27.1% | 29% |
| Last 6 months | −17.2% | 26% |
| Last 3 months | −13.3% | 36% |
The price is 45.2% below its all-time high of ₹667.55 (20 Sept 2024). Stocks more than 20% below their peak have their score halved, so 29 became 15.
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Dabur India Ltd: 0.4 × 29 + 0.4 × 26 + 0.2 × 36 = 29, halved to 15 because the price is more than 20% below its all-time high.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Dabur India Ltd's management said in earlier quarters
- Q1 FY27 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q1 FY26 earnings call →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
Others in Personal Products this season
- Aakaar Medical (Q2 FY27)
Revenue from operations in H1 FY27: INR 43.72 Cr, up 72.6% YoY from INR 25.32 Cr in H1 FY26 (Page 12, 11, 4) . Key investor presentation takeaways from Aakaar M
- Recode Studios Ltd (Q4 FY26)
The company plans to sustain marketing spends at about 20% of revenue to support growth and brand visibility, implying continued focus on operating profits…
- Godrej Consumer Products Ltd (Q2 FY27)
Consolidated net sales for Q2 FY2027: ₹4,396 crore, up 19% year-on-year; constant currency growth 15% (Page 8) . Key investor presentation takeaways from Godrej
- Colgate-Palmolive (India) Ltd (Q2 FY27)
1,692 crore, up 12.2% year-on-year from Rs. Key results statement takeaways from Colgate-Palmolive (India) Ltd's Q2 FY27 results statement — and how it ranks ag
